Header cover image

Norwegian (OSEAX) Healthcare Sector Analysis

UpdatedJun 18, 2024
DataAggregated Company Financials
Companies25
  • 7D-4.1%
  • 3M-0.7%
  • 1Y-39.1%
  • YTD-31.3%

Over the last 7 days, the Healthcare industry has dropped 1.7%, driven by a pullback from Nykode Therapeutics of 7.7%. In contrast, Lifecare has gained 29%. However, the industry is down 38% over the past year. Earnings are forecast to grow by 25% annually.

Sector Valuation and Performance

Has the Norwegian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 18 Jun 2024kr22.2bkr4.1b-kr949,245,115.2515.4x-23.4x5.4x
Thu, 16 May 2024kr22.1bkr4.2b-kr1,130,385,793.5117.6x-19.6x5.2x
Sat, 13 Apr 2024kr22.0bkr4.2b-kr1,120,572,024.8828.3x-19.6x5.2x
Mon, 11 Mar 2024kr21.6bkr4.2b-kr1,083,766,523.7027.7x-20x5.2x
Wed, 07 Feb 2024kr28.5bkr4.1b-kr1,281,250,190.4623.2x-22.3x7x
Fri, 05 Jan 2024kr30.5bkr4.1b-kr1,580,205,927.0023.1x-19.3x7.5x
Sun, 03 Dec 2023kr27.4bkr4.1b-kr1,584,880,761.0022.1x-17.3x6.7x
Tue, 31 Oct 2023kr25.2bkr3.5b-kr1,861,380,870.0029.6x-13.6x7.3x
Thu, 28 Sep 2023kr27.6bkr3.5b-kr1,798,967,861.0033.7x-15.4x7.8x
Sat, 26 Aug 2023kr28.0bkr3.5b-kr1,820,841,336.0032.2x-15.4x7.9x
Mon, 24 Jul 2023kr29.8bkr3.4b-kr1,814,603,064.0030.1x-16.4x8.8x
Wed, 21 Jun 2023kr30.2bkr3.4b-kr1,828,365,178.0042.5x-16.5x8.9x
Fri, 19 May 2023kr29.9bkr3.4b-kr1,806,456,809.0045.4x-16.5x8.8x
Sun, 16 Apr 2023kr30.3bkr3.1b-kr1,882,014,994.0031.4x-16.1x9.6x
Tue, 14 Mar 2023kr28.7bkr3.1b-kr1,874,252,429.0031.1x-15.3x9.2x
Thu, 09 Feb 2023kr33.8bkr3.6b-kr1,861,415,280.0034.9x-18.1x9.4x
Sat, 07 Jan 2023kr33.1bkr3.6b-kr1,837,174,687.0034.3x-18x9.2x
Mon, 05 Dec 2022kr33.9bkr3.6b-kr1,833,582,720.0038.5x-18.5x9.5x
Wed, 02 Nov 2022kr32.8bkr3.5b-kr1,752,618,090.0038.5x-18.7x9.4x
Fri, 30 Sep 2022kr30.1bkr3.5b-kr1,777,728,238.0054.4x-16.9x8.7x
Sun, 28 Aug 2022kr36.4bkr3.4b-kr1,700,410,675.0060.5x-21.4x10.8x
Tue, 26 Jul 2022kr37.1bkr3.3b-kr1,741,780,225.0083.1x-21.3x11.3x
Thu, 23 Jun 2022kr36.7bkr3.3b-kr1,703,493,240.0054.2x-21.6x11.1x
Sat, 21 May 2022kr37.9bkr3.6b-kr1,248,837,190.0046.4x-30.3x10.6x
Mon, 18 Apr 2022kr42.9bkr3.4b-kr1,202,462,938.0044.1x-35.7x12.5x
Wed, 16 Mar 2022kr40.7bkr5.1bkr214.4m37.8x189.8x7.9x
Fri, 11 Feb 2022kr49.4bkr4.9bkr272.7m44.3x181x10x
Sun, 09 Jan 2022kr61.6bkr4.5b-kr114,799,015.0061.5x-537x13.8x
Tue, 07 Dec 2021kr58.3bkr4.5b-kr62,066,567.0064.1x-939.5x12.9x
Thu, 04 Nov 2021kr62.4bkr4.7bkr342.6m50.9x182.1x13.2x
Sat, 02 Oct 2021kr60.9bkr4.7bkr391.5m65.2x155.6x13.1x
Mon, 30 Aug 2021kr64.2bkr4.6bkr425.6m61.7x150.9x13.8x
Tue, 06 Jul 2021kr61.4bkr4.6bkr425.6m55.3x144.2x13.2x
Price to Earnings Ratio

144.2x


Total Market Cap: kr61.4bTotal Earnings: kr425.6mTotal Revenue: kr4.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Healthcare Sector Price to Earnings3Y Average -26.8x202220232024
Current Industry PE
  • Investors are pessimistic on the Norwegian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 9.6x is higher than the industry's current PS ratio of 5.5x.
Past Earnings Growth
  • Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 3.9% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare sector?

NO Market-1.79%
Healthcare-4.10%
Healthcare Services0.63%
Life Sciences0%
Pharma-0.36%
Medical Equipment-1.62%
Healthtech-3.54%
Biotech-7.07%
Industry PE
  • Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 79.0%, which is lower than the prior year's growth of 654.9% per year.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 79% over the next 5 years.
  • However this is lower than its past earnings growth rate of 655% per year.
  • In contrast, the Biotech industry is expected to see its earnings decline by 8.5% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LYTIX Lytix Biopharmakr9.2032.6%
+kr112.1m
21.1%PS31.4x
LIFE Lifecarekr2.5433.5%
+kr86.0m
25.7%PS31.5x
INIFY INIFY Laboratorieskr7.956.0%
+kr20.4m
-12.3%n/a
PHO Photocurekr65.000.8%
+kr13.6m
32.9%PE365.4x
CARA Carasentkr18.700.8%
+kr10.8m
19.1%PS5.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CODE

kr0.50

CodeLab Capital

7D

7.8%

1Y

18.1%

LIFE

kr2.54

Lifecare

7D

33.5%

1Y

25.7%

ULTI

kr8.56

Ultimovacs

7D

-6.7%

1Y

-89.1%

HBC

kr2.03

Hofseth BioCare

7D

1.0%

1Y

-27.2%

LYTIX

kr9.20

Lytix Biopharma

7D

32.6%

1Y

21.1%

NYKD

kr14.32

Nykode Therapeutics

7D

-12.0%

1Y

-51.5%

MEDI

kr176.00

Medistim

7D

-3.3%

1Y

-34.8%

AZT

kr24.35

ArcticZymes Technologies

7D

-2.6%

1Y

-36.1%

NORDH

kr31.10

Nordhealth

7D

-8.0%

1Y

22.0%

NAVA

kr34.30

Navamedic

7D

0.9%

1Y

-12.1%

CARA

kr18.70

Carasent

7D

0.8%

1Y

19.1%

INIFY

kr7.95

INIFY Laboratories

7D

6.0%

1Y

-12.3%

NANOV

kr2.00

Nordic Nanovector

7D

-18.3%

1Y

-22.2%